The novel treatment of the medication represents a major breakthrough in the handling of type 2 diabetes. Unlike existing drugs, tirzepatide targets dual pathways – GLP-1 and GIP – leading to enhanced sugar https://tirzepatide-peptide061117.targetblogs.com/42323483/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment